# Contrast-Enhanced Ultrasound Diagnosis of Acute Appendicitis

> **NCT03295656** · PHASE1 · WITHDRAWN · sponsor: **Boston Children's Hospital**

## Conditions studied

- Appendicitis Acute

## Interventions

- **DRUG:** Sulfur hexafluoride lipid-type A microspheres

## Key facts

- **NCT ID:** NCT03295656
- **Lead sponsor:** Boston Children's Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2020-07-15
- **Primary completion:** 2020-07-15
- **Final completion:** 2020-07-15
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Unanticipated delays.
- **Last updated:** 2020-07-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03295656

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03295656, "Contrast-Enhanced Ultrasound Diagnosis of Acute Appendicitis". Retrieved via AI Analytics 2026-05-30 from https://api.ai-analytics.org/clinical/NCT03295656. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
